1Andrew CG, Drachman DB, Pestrunk A, et al. Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulium toxin and denervation. Science, 1984, 223: 714-716.
2Zoll J, Jongen P, Galama J, et al. Coxsackievims B1-induced murine myosistis: no evidence for viral persistence. J Gen Viral,1993, 74: 2071-2076.
3Travers RL, Hughes GR, Cambridge G, et al. Coxsackie B neutralisation titles in polymyositis/dermatomyositis. Lancet, 1977,1 : 1268.
5Yoshino M, Suzuki S, Adachi K, et al. High incidence of acute myositis with type A influenza virus infection in the elderly. Intern Med, 2000, 39: 431-432.
6Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis, 1996, 22: 642-649.
7Davis LE, Kornfeld M. Experimental influenza B viral myositis. J Neurol Sci, 2001, 187 : 61-67.
8Nakanishi K, Ishikawa M, Nakauchi M, et al. Antibody to hepatitis B e positive hepatitis induced by withdrawal of steroid therapy for polymyositis: response to interferon-or and cyclosporin A. Intern Med, 1998, 37: 519-522.
10Tsuruta Y, Yamada T, Yoshimura T, et al. Inclusion body myositis associated with hepatitis C virus infection. Fukuoka Igaku Zasshi,2001,92 : 370-376.
